Skip to content. | Skip to navigation

Sections

Personal tools

Log in

You are here: Home → Graduate Program → Courses → BIOINF-618

Home
Graduate Program
- Admissions
- Courses
  - BIOINF-463
  - BIOINF-523
  - BIOINF-527
  - BIOINF 545
  - BIOINF-547
  - BIOINF-551
  - BIOINF-555
  - BIOINF-563
  - BIOINF-575
  - BIOINF-665
  - BIOINF-618
  - BIOINF-601
  - BIOINF-602
- Curriculum
- Staff
- Students
- Alumni
- Ann Arbor
- History
Research/Faculty
Events
Contact

Search: Advanced Search…

News: Bioinformatics Graduate student Conner Sandefur to participate in NIAID INRO Program Nov 19, 2009; Seminar by Dr. Brian Athey - "The Relationship Between Informatics and Biomedical Research and Education: Current and Future Perspectives" - Sep. 30, 4pm Sep 28, 2009; National Institutes of Health, the NephCure Foundation and University of Michigan support study of nephrotic syndrome Sep 24, 2009; More news…

BIOINF-618

— filed under: Elective

Topics in Signaling Therapeutics - 2 Credits

This course is designed to link state-of-the-art cancer therapeutics to fundamentals in signal transduction, cancer genetics, systems biology and bioinformatics. Topics to be covered in include concepts of genetic and epigenetic factors in cancer, cancer modeling and bioinformatics, tyrosine kinase therapeutics in hematological malignancies and solid tumors (Gleevec/STI571 and beyond), anti-angiogenic agents, proteasome inhibitors, DNA-histone modifying agents. The course will consist of a mixture of didactic lectures and student presentations. Evaluation will be based on oral presentation and NRSA-style proposal writing.

Document Actions

Copyright 2009 by The Regents of the University of Michigan
Powered by Plone